CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,030,805
- in 10 filings, $173K under 10b5-1 plans
Net −$1,030,805. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Pande Atul Director | Option exercise 10b5-1 | +3,000 | $8.43 | $25K | 119,731 |
| 2026-11-11 | Pande Atul Director | Sale 10b5-1 | −3,000 | $36.00 | $108K | 116,731 |
| 2026-11-11 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 62,181 | ||
| 2026-08-28 | Pande Atul Director | Option exercise 10b5-1 | +1,500 | $8.43 | $13K | 118,231 |
| 2026-08-28 | Pande Atul Director | Sale 10b5-1 | −1,500 | $43.27 | $65K | 116,731 |
| 2026-08-28 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 65,181 | ||
| 2026-07-24 | Pande Atul Director | Option exercise 10b5-1 | +1,500 | $8.43 | $13K | 118,231 |
| 2026-07-24 | Pande Atul Director | Sale 10b5-1 | −1,500 | $39.80 | $60K | 116,731 |
| 2026-07-24 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 66,681 | ||
| 2026-06-26 | Pande Atul Director | Option exercise 10b5-1 | +1,500 | $8.43 | $13K | 118,231 |
| 2026-06-26 | Pande Atul Director | Sale 10b5-1 | −1,500 | $38.01 | $57K | 116,731 |
| 2026-06-26 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 68,181 | ||
| 2026-06-15 | Pande Atul Director | Option exercise 10b5-1 | +1,500 | $8.43 | $13K | 118,231 |
| 2026-06-15 | Pande Atul Director | Sale 10b5-1 | −1,500 | $34.02 | $51K | 116,731 |
| 2026-06-15 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,500 | 69,681 | ||
| 2026-05-20 | Pande Atul Director | Option exercise 10b5-1 | +6,000 | $8.43 | $51K | 122,731 |
| 2026-05-20 | Pande Atul Director | Sale 10b5-1 | −6,000 | $32.00 | $192K | 116,731 |
| 2026-05-20 | Pande Atul Director | Option exercise · Stock Option (right to buy) 10b5-1 | −6,000 | 270,252 | ||
| 2026-04-07 | Pande Atul Director | Grant or award | +13,880 | 116,731 | ||
| 2026-04-07 | Pande Atul Director | Grant or award · Stock Option (right to buy) | +7,061 | 7,061 |
Page 1 of 2 · 23 trades